Sky Century Investment (SKYI) Cash from Operations Growth (1y) (2013 - 2026)
Sky Century Investment (SKYI) Cash from Operations Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 425.00% |
| 10 | Sky Century Investment | 944,514.46 | 944,250.46 | 26,045.00 | -198.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -198.53% |
| Feb 28, 2026 | 123.28% |
| Nov 30, 2025 | 42.64% |
| Aug 31, 2025 | -58.94% |
| May 31, 2025 | 1,120.19% |
| Feb 28, 2025 | 11.52% |
| Feb 28, 2014 | 2.88% |
| Aug 31, 2013 | -2.50% |